Test Price
2,800 AEDโ Home Collection Available
DSP Gene ARVC8 Genetic Test in Dubai | DNA Labs UAE | 2,800 AED
Executive Summary & Core Metrics
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 15189 Accredited NGS Processing.
Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Daily 8 AM โ 11 PM).
Clinical Guidance: Telephonic Post-Test Clinical Guidance by Consultant Medical Genetics.
Insurance Verification: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The DSP Gene ARVC8 Genetic Test detects mutations in the desmoplakin (DSP) gene responsible for Arrhythmogenic Right Ventricular Cardiomyopathy Type 8, a heritable heart muscle disorder linked to life-threatening arrhythmias. This next-generation sequencing (NGS) assay is the gold standard for confirming a clinical suspicion, enabling cascade family screening, and guiding sports participation clearances under UAE cardiac guidelines.
| Feature | Our Test (NGS Gold Standard) | Closest Alternative (Single-Gene Sanger) |
|---|---|---|
| Diagnostic Precision | 99.9% Sensitivity for all DSP mutation types | ~95% sensitivity; may miss large deletions/duplications |
| Method | Next-Generation Sequencing (NGS) | Sanger Sequencing (single-amplicon) |
| Turnaround Time | 3โ4 Weeks | 4โ6 Weeks |
| UAE DHA Compliance | Facility License 1143, ISO 15189 Accredited | Variable |
Physician Insight & Safety Protocols
โAs a Consultant in Medical Genetics, I emphasize that genetic testing for ARVC8 must be accompanied by comprehensive pre- and post-test counseling. Results from the DSP gene sequencing must be correlated with clinical findings, family history, and ECG/imaging data. A negative result does not eliminate the possibility of other genetic cardiomyopathies, and a positive result informs critical decisions concerning lifestyle, sports activities, and family screening.โ โ Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA ID: 9294403
Medication & Clinical Advisory
Medication Advisory
Do not alter or discontinue prescribed cardiac medications based solely on genetic test results without prior consultation with your treating cardiologist. The genetic report provides diagnostic insight and does not replace clinical medication management.
Clinical Exclusion & Safety Red Flags
Exclusion Criteria & Safety Red Flags
- Do not provide a sample if you are currently experiencing acute chest pain, syncope (fainting), or severe palpitationsโseek emergency evaluation first.
- Known allergy to antiseptics or phlebotomy supplies must be communicated to the collection team prior to the appointment.
- Emergency Warning: If you develop sudden irregular heartbeat, loss of consciousness, or chest tightness after sample collection, call 998 or go to the nearest emergency room immediately.
Patient FAQ & Clinical Guidance
1. What is the DSP gene ARVC8 test and who should consider it?
This NGS test detects DSP gene mutations causing ARVC8, a hereditary cardiomyopathy. It is vital for family cascade screening and athletic clearance. Individuals with a family history of sudden cardiac death, unexplained syncope, or a confirmed ARVC diagnosis in a first-degree relative should pursue testing following genetic counseling. It is also utilized for pre-symptomatic detection in at-risk family members.
2. How is the test performed and what is the sample requirement?
A mandatory pre-test genetic counseling session is scheduled to review clinical history and construct a pedigree chart. Our VIP mobile phlebotomy team then collects the specimen using cold-chain logistics. The test accepts whole blood (8-10 mL in EDTA tubes), extracted DNA, or a single drop on an FTA card. Results are typically available within 3โ4 weeks from sample receipt at the laboratory.
3. Does health insurance cover this test in the UAE?
Insurance coverage for genetic cardiomyopathy testing is often applicable when ordered by a DHA-licensed cardiologist and deemed medically necessary. Major UAE insurers including Daman, AXA, and Oman Insurance generally reimburse these panels. Contact our billing support team via WhatsApp at +971 54 548 8731 for a direct pre-approval check against your specific policy.
UAE Regulatory & Data Privacy Adherence
This service is fully compliant with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) governing the processing of genetic data. It strictly adheres to Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All clinical safety and patient consent protocols are conducted in accordance with Federal Decree-Law No. 4 of 2016 on Medical Liability. Your genetic information is processed confidentially and stored securely under DHA regulatory standards.
Clinical & Logistical Metadata
| Test Name | DSP Gene ARVC8 Genetic Test (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3โ4 Weeks |
| Sample Type / Matrix | Whole Blood (EDTA), Extracted DNA, or FTA Card Blood Spot |
| Methodology Used | Next-Generation Sequencing (NGS) โ Full Gene Sequencing |
| ICD-10-CM Code | I42.8 |
| LOINC Code | 83890-4 |
| DHA Facility License & Laboratory Address | DHA License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians